Author name: Dr. Rathod Medical Foundation

Gallbladder cancer is diagnosed through a sequence of imaging that starts with ultrasound and escalates to CT, MRI, and EUS depending on what’s found. The difficulty is that early disease produces no specific symptoms, so a large share of cases turn up incidentally, either on a scan done for something else or on histology after a routine gallbladder removal. Accurate staging once a lesion is identified is what determines whether treatment is possible, which makes the diagnostic pathway as important as the finding itself. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Gallbladder cancer is one of the hardest GI cancers to catch early because the gallbladder doesn’t announce trouble until late. When a suspicious thickening or mass shows up, the priority is accurate staging, and that’s where EUS adds detail that a standard scan simply can’t provide.” What Tests Are Used to Diagnose Gallbladder Cancer? Diagnosis builds in steps, each test answering a question the previous one couldn’t. Ultrasound comes first, picking up gallbladder wall thickening, masses, or polyps that warrant further investigation, though it can’t confirm cancer on its own. CT and MRI map the extent, showing whether a tumour has spread to the liver, bile ducts, or distant sites, which is essential for staging once ultrasound raises suspicion. EUS adds the detail external scans miss, assessing tumour depth and nearby lymph nodes from inside the GI tract at a proximity no surface imaging can reach. When tissue confirmation is needed, EUS-guided fine needle aspiration samples the lesion directly, settling an ambiguous imaging picture without surgery. Getting this sequence right requires a gallbladder cancer specialist who can interpret each step and decide what the next investigation should be. Why Is Gallbladder Cancer So Often Found Late? The diagnostic challenge isn’t usually the tests themselves but how late the suspicion arises. No specific early symptoms exist. The vague right upper abdominal discomfort that gallbladder cancer produces is identical to ordinary gallstone disease, so it rarely triggers cancer-focused investigation. Many cancers surface incidentally on histology after a gallbladder is removed for gallstones, meaning the diagnosis arrives only once the organ is already out. Imaging overlap muddies the picture, because gallstones and chronic inflammation can mask or mimic an early tumour on ultrasound, delaying the escalation to CT or EUS. High-risk patients often go unmonitored, as those with large gallstones or gallbladder polyps frequently aren’t placed on the surveillance that would catch a developing cancer early. For patients dealing with gallbladder-related complications, understanding how endoscopic diagnosis works in the biliary system is a useful background. Read more on bile leakage to see how endoscopic techniques diagnose and manage biliary complications after gallbladder surgery. Why Choose Dr. Vipulroy Rathod for Gallbladder Cancer? Dr. Vipulroy Rathod has been diagnosing hepatobiliary cancers at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 gives him the staging tool most centres don’t deploy for gallbladder lesions that surface imaging can’t fully characterise. Patients with an ambiguous gallbladder finding often get a clear diagnosis and accurate stage in a single workup rather than a series of scattered scans. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for gallbladder cancer diagnosis and endoscopic staging. Book Appointment Call now Frequently Asked Questions How is gallbladder cancer diagnosed? Gallbladder cancer is diagnosed through ultrasound as the first step, followed by CT or MRI for staging, and EUS with fine needle aspiration for tissue confirmation and assessment of local spread. What is the most accurate test for gallbladder cancer? EUS provides the most accurate local staging by assessing tumour depth and lymph node involvement, and allows fine needle aspiration for tissue diagnosis when imaging findings are inconclusive. Can gallbladder cancer be detected on ultrasound? Ultrasound can detect gallbladder wall thickening, masses, or polyps suggestive of cancer, but further imaging with CT, MRI, or EUS is needed to confirm the diagnosis and stage the disease. Is gallbladder cancer often found incidentally? Yes. Many gallbladder cancers are found incidentally on histology after gallbladder removal for gallstones, or on imaging performed for an unrelated reason, rather than through symptoms. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Open surgery is no longer the default for colorectal cancer the way it was two decades ago. Early-stage tumours and large precancerous polyps are now routinely removed through the colonoscope itself, and even cases that do need an operation are often handled laparoscopically rather than through a large incision. What determines the route is stage, depth, and location, which makes accurate workup before treatment the single most important factor in keeping a patient out of open surgery. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “The patients who end up in open surgery are often the ones who presented late. Caught early, a colorectal cancer confined to the lining can frequently come out through the scope in a day procedure. The earlier we see it, the less invasive the treatment, which is the entire argument for screening.” What Are the Non-Surgical Treatment Options? The treatment route depends almost entirely on how early the cancer is caught. Removing the lesion endoscopically through EMR or ESD handles early cancers confined to the mucosa, taking the tumour out through the colonoscope with no incision and same-day discharge. Large or flat polyps that standard polypectomy can’t manage come out via EMR before they ever progress to invasive cancer. When a cancer sits slightly deeper but hasn’t spread, laparoscopic resection removes the affected segment through small keyhole incisions instead of an open laparotomy. For rectal cancers, transanal endoscopic approaches reach early lesions through the anus, avoiding both abdominal incisions and, in selected cases, a permanent stoma. Which of these applies comes down to staging, and a colorectal cancer specialist determines the least invasive route that still treats the disease completely. When Is Open Surgery Still Necessary? Not every case can avoid open surgery, and knowing the limits matters as much as knowing the options. Deep invasion into the bowel wall takes a cancer past what any endoscopic technique can safely remove, and resection becomes necessary. If lymph nodes are involved, the cancer has spread beyond a local problem, and surgery with node clearance is required regardless of how the primary lesion looks. Large or obstructing tumours blocking the bowel usually need surgical removal, often urgently, before endoscopic options can even be considered. Once a tumour is technically complex in its position or extent, open surgery offers the control that keyhole or endoscopic routes can’t reliably provide. Catching colorectal cancer before it reaches these stages is what keeps treatment minimally invasive, and that starts with knowing who needs screening. Read more on colon cancer screening to understand who should be screened and when early detection changes the treatment route entirely. Why Choose Dr. Vipulroy Rathod for Colorectal Cancer? Dr. Vipulroy Rathod has been treating colorectal cancer endoscopically at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 means the staging that decides between an endoscopic, laparoscopic, or open route happens accurately in the same workup. Patients referred for open surgery on lesions that were actually suitable for endoscopic removal frequently find a less invasive option available. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for colorectal cancer assessment and minimally invasive endoscopic treatment. Book Appointment Call now Frequently Asked Questions Can colorectal cancer be treated without open surgery? Yes. Early-stage colorectal cancers and large polyps can be removed endoscopically through EMR or ESD, while more advanced cases may be treated with laparoscopic surgery rather than open surgery. What is endoscopic treatment for colorectal cancer? Endoscopic treatment removes early colorectal cancers and precancerous polyps through a colonoscope using EMR or ESD, without any external incision and usually as a day procedure. When is open surgery still needed for colorectal cancer? Open surgery is needed when the cancer has invaded deeper bowel layers, spread to lymph nodes, or is too large or complex for endoscopic or laparoscopic removal. Is endoscopic colorectal cancer treatment safe? Yes. For suitable early-stage lesions, endoscopic removal is safe, avoids general anaesthesia in many cases, preserves the bowel, and allows same-day discharge with faster recovery than open surgery. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

EMR and ESD are both endoscopic techniques for removing early GI tumours without open surgery, but they aren’t interchangeable. EMR lifts and snares a lesion off in pieces, while ESD dissects beneath it to take the whole thing out in one specimen. The choice between them comes down to lesion size, depth, and whether the pathologist needs an intact margin, which means the better technique is the one matched correctly to the lesion rather than the one that’s better in the abstract. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Patients often ask which procedure is superior, and the honest answer is that it depends entirely on what we’re removing. A small polyp doesn’t need ESD. A large flat lesion where margins matter for staging shouldn’t have EMR. Getting that decision right before the procedure is what actually determines the outcome.” How Do EMR and ESD Differ? The two procedures share a goal but differ in how they reach it. Factor EMR ESD Removal method Snare, in pieces Dissection, single piece Best lesion size Under 2 cm Above 2 cm Specimen quality Fragmented En bloc, intact margins Procedure time Shorter Longer Recurrence risk Higher for large lesions Lower Snaring the lesion is how EMR works, lifting it with a submucosal injection and cutting it free, which suits smaller superficial lesions well. ESD dissects under the lesion with a fine knife, freeing it in one intact piece. That single specimen is what gives pathologists a clean margin to assess. For lesions above 2 cm, EMR usually means piecemeal removal, and fragmented specimens make accurate margin assessment harder and recurrence more likely. Where en bloc removal matters for staging, ESD is the better choice despite taking longer and demanding more technical skill. Choosing correctly needs accurate pre-procedure staging, which is where a specialist in endoscopic resection determines which technique fits the lesion in front of them. Which One Is Right for a Given Tumour? There’s no universally superior technique, only the right match for the lesion. Small, clearly superficial lesions do well with EMR. It’s faster, simpler, and carries a lower complication rate. Large or flat lesions belong to ESD, where en bloc removal gives a complete specimen and a markedly lower recurrence rate. If the lesion’s depth is uncertain, EUS staging settles it before anything is cut, and that assessment often decides EMR versus ESD on its own. Once invasion beyond the mucosa is suspected, neither technique is appropriate and surgery becomes the safer route, which is why staging always precedes the resection decision. Understanding where these procedures sit within endoscopy’s broader treatment role helps put the choice in context. Read more on role of endoscopy to see how EMR and ESD fit alongside endoscopy’s wider diagnostic and treatment capabilities. Why Choose Dr. Vipulroy Rathod for EMR and ESD? Dr. Vipulroy Rathod has been performing both EMR and ESD at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 means the staging that decides between the two techniques happens accurately in the same workup rather than as guesswork. Patients referred for surgery on lesions that were actually suitable for endoscopic removal frequently find a less invasive route available. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for EMR, ESD, and endoscopic GI tumour removal. Book Appointment Call now Frequently Asked Questions What is the difference between EMR and ESD? EMR removes lesions in pieces using a snare, while ESD dissects beneath the lesion to remove it in a single piece, allowing more accurate margin assessment for larger or deeper lesions. Which is better for GI tumours, EMR or ESD? It depends on lesion size and depth. EMR suits smaller superficial lesions, while ESD is preferred for larger lesions above 2 cm or where en bloc removal is needed for accurate staging. Is ESD more risky than EMR? ESD carries a slightly higher risk of perforation and bleeding due to its complexity, but in experienced hands it offers higher complete resection rates and lower recurrence than EMR for suitable lesions. Can EMR and ESD remove early cancer? Yes. Both remove early-stage GI cancers confined to the mucosa, but ESD allows en bloc removal that gives pathologists a complete specimen for accurate margin and depth assessment. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Many IBD complications that once meant surgery are now treated through the endoscope. Strictures, dysplastic lesions, perianal abscesses, and acute bleeding in Crohn’s and ulcerative colitis patients can be managed in a day procedure that leaves the bowel intact. Surgery still has a place in IBD care, but for complications a scope can reach, it has stopped being the automatic first answer it used to be. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “IBD patients used to face surgery almost inevitably once complications developed. That’s no longer true in most cases. Balloon dilation, endoscopic resection, EUS-guided drainage these have changed the conversation from when do we operate to whether we need to operate at all, and for a lot of patients the answer is we don’t.” What Complications Can Endoscopy Now Manage? Four interventions account for most of the shift away from surgery. Balloon dilation opens short fibrous strictures in Crohn’s without resecting bowel. It can be repeated over years, which spares patients the cumulative damage of multiple surgeries. Removing dysplastic lesions in ulcerative colitis through EMR or ESD keeps patients out of the colectomy pathway, provided the lesion is well demarcated and confined to the mucosa on EUS. If a perianal or abdominal abscess develops in Crohn’s, EUS-guided drainage clears it through the rectal wall. No general anaesthetic, no external wound, much faster recovery than operative drainage. Acute bleeding during a flare gets controlled with APC or clipping at the bleeding point, sparing a patient with active colitis the substantially higher risk of emergency surgery. A specialist in IBD management can assess which of these applies before any surgical referral is made. How Does Endoscopy Monitor IBD Between Flares? Monitoring matters as much as treating. It’s how complications get caught early. Mucosal healing is the treatment target now, not symptom control, and only colonoscopy with biopsies can confirm it. A patient who feels fine may still have active inflammation underneath. Dysplasia surveillance in long-standing ulcerative colitis runs on a structured colonoscopy schedule. Regular biopsies catch early change that’s still treatable through the scope. Symptom improvement isn’t the same as mucosal healing. Endoscopic confirmation after starting a biologic tells you whether the drug is actually working, and the treatment decision changes accordingly. When Crohn’s affects small bowel beyond colonoscopic reach, capsule endoscopy or balloon-assisted enteroscopy covers the segments a standard scope can’t, so disease activity gets tracked across its full extent. A closer look at what colonoscopy finds in IBD, and where it falls short, is worth reading first. Read more on Crohn’s detection to see how colonoscopy fits into diagnosis and monitoring for Crohn’s disease. Why Choose Dr. Vipulroy Rathod for IBD? Dr. Vipulroy Rathod has been managing IBD endoscopically at Fortis Hospital Mulund for over 30 years, with EUS since 1998 adding a drainage and staging capability most IBD centres don’t deploy for perianal and abdominal complications. Patients referred for surgical opinions on strictures or colonic dysplasia often find an endoscopic route their previous gastroenterologist hadn’t explored. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for IBD endoscopic assessment, stricture management, and dysplasia surveillance. Book Appointment Call now Frequently Asked Questions Can endoscopy replace surgery for IBD? In many cases yes, with balloon dilation for strictures, EMR for dysplastic lesions, and EUS-guided drainage for abscesses addressing complications that previously required open surgery. What endoscopic procedures are used for IBD? Colonoscopy with biopsy for monitoring, balloon dilation for intestinal strictures, endoscopic mucosal resection for dysplasia, and EUS-guided drainage for abscesses are the main procedures used in IBD management. Is endoscopic treatment for IBD safe? Yes. Endoscopic procedures carry significantly lower risk than open surgery, with shorter recovery times and no need for general anaesthesia in most cases. Does endoscopy cure IBD? Endoscopy does not cure IBD but manages its complications and monitors disease activity and treatment response, reducing the need for surgical intervention in many patients. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Alcoholic liver disease and non-alcoholic fatty liver disease both deposit fat in the liver and can both progress to cirrhosis, but they arrive there through entirely different mechanisms and need different clinical approaches. ALD is driven by alcohol; NAFLD develops in people who drink little or none, tied instead to obesity, insulin resistance, and metabolic syndrome. With NAFLD now affecting an estimated 25 to 38% of the Indian adult population, confusing the two or missing either diagnosis carries real consequences for long-term liver health. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Both conditions are underdiagnosed because neither produces reliable symptoms until significant liver damage has already occurred. The patient with NAFLD often has no idea their liver is affected until a routine ultrasound picks it up, and by the time ALD causes clinical symptoms, the disease has frequently moved well past the fatty liver stage.” How Do ALD and NAFLD Differ? On ultrasound alone, a radiologist can’t always tell them apart; the distinction comes from clinical history, blood patterns, and staging investigations. Factor Alcoholic Liver Disease NAFLD Primary cause Heavy alcohol use Obesity, insulin resistance Typical patient Any adult with significant intake Diabetic, overweight, metabolic syndrome Key blood marker AST:ALT ratio above 2:1 ALT typically higher than AST Reversibility High if alcohol stopped early Reversible with weight loss in early stages Progression risk Faster with continued drinking Slower but accelerated by diabetes Sustained heavy alcohol use sets off a cycle of hepatic inflammation, fat accumulation, and progressive scarring that moves toward cirrhosis at a pace considerably faster than NAFLD, and the defining feature clinically is that the damage halts and partially reverses when drinking stops but accelerates sharply when it doesn’t. What makes NAFLD harder to catch is that the patients most at risk overweight, diabetic, dyslipidaemic don’t think of themselves as having a liver disease, and the metabolic drivers including central obesity, insulin resistance, and hypertension work together to push fibrosis forward even without any alcohol involvement, often across years of entirely normal liver function tests that provide false reassurance. When both conditions coexist in the same patient, which happens more often than expected in someone with metabolic syndrome who also drinks at harmful levels, the AST to ALT ratio provides a useful but imperfect guide, and a FibroScan or biopsy becomes the investigation that separates a clinical assumption from an actual answer. Getting staging right before committing to a management plan matters because the patient who gets lifestyle advice for what turns out to be advanced fibrosis, and the patient who gets referred for a transplant workup when their disease was still reversible, both suffered from the same failure of accurate baseline assessment. A fatty liver finding on ultrasound needs proper staging rather than a repeat scan in six months a fatty liver specialist can determine what’s actually driving it and how far along the fibrosis has already progressed. How Is Each Condition Managed? Each has one non-negotiable intervention, and everything else builds around it. Stop drinking. In ALD that’s not one recommendation among several it’s the treatment, and continued alcohol use in the context of alcoholic hepatitis or early cirrhosis carries a mortality risk no pharmacological intervention currently overcomes without abstinence running alongside it. Achieving 7 to 10% body weight reduction is the most reliably evidence-backed intervention in NAFLD, producing measurable histological improvement in both hepatic steatosis and fibrosis across multiple patient populations and remaining first-line ahead of pharmacotherapy even for patients who arrive convinced a medication will do what lifestyle hasn’t yet managed. Thiamine, folate, and protein deficiencies are routine findings in patients with ALD and compound the liver damage if not corrected alongside cessation, which is why the patient who stops drinking but receives no nutritional input often fails to recover as expected despite doing the one thing that should theoretically be enough. GLP-1 receptor agonists and SGLT-2 inhibitors have shown hepatic benefit well beyond glycaemic control in recent NAFLD data, and for diabetic patients in particular the most productive treatment conversation is increasingly the one that happens between the gastroenterologist and the treating endocrinologist rather than either working through it independently. Both conditions raise long-term GI cancer risk if they progress to cirrhosis, and the metabolic factors that drive NAFLD connect to broader cancer risk worth understanding. Read more on colon cancer screening to see how overlapping metabolic risk factors including fatty liver influence long-term GI cancer risk. Why Choose Dr. Vipulroy Rathod for Liver Disease? Dr. Vipulroy Rathod has been managing ALD and NAFLD at Fortis Hospital Mulund for over 30 years, regularly seeing patients who’ve had fatty liver flagged on imaging with no staging of how advanced the fibrosis actually is. FibroScan assessment and EUS when indicated quantify structural damage accurately in the same workup, and patients who arrive managing what they believe is mild fatty liver frequently leave with a clearer picture of where their disease sits and what’s realistically needed. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for alcoholic liver disease and NAFLD assessment, staging, and management. Book Appointment Call now Frequently Asked Questions What is the main difference between alcoholic liver disease and NAFLD? Alcoholic liver disease is caused by heavy alcohol consumption, while NAFLD occurs in people who drink little or no alcohol and is driven by obesity, insulin resistance, and metabolic syndrome. Can NAFLD progress to cirrhosis? Yes. NAFLD can progress through steatohepatitis and fibrosis to cirrhosis and liver failure, particularly in patients with diabetes, obesity, or metabolic syndrome who do not modify their lifestyle. How is alcoholic liver disease diagnosed? Diagnosis involves a detailed alcohol history, liver function tests, ultrasound, and in some cases FibroScan or liver biopsy to assess the degree of fibrosis and rule out concurrent causes. Is fatty liver reversible? Early-stage fatty liver in both ALD and NAFLD is potentially reversible with alcohol cessation or weight loss respectively, but once significant fibrosis develops the damage becomes

Gallbladder cancer is one of the more deceptive GI malignancies because it produces no reliable symptoms in its early stages, and the signs that do appear upper abdominal discomfort, nausea, mild jaundice overlap so closely with common biliary complaints that most patients are already at an advanced stage before the diagnosis is made. India carries one of the highest gallbladder cancer incidence rates in the world, particularly in northern and eastern states, which makes awareness of the risk profile and early clinical signals more relevant here than almost anywhere else. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Gallbladder cancer is frequently found incidentally on imaging done for something else, or on histology after a routine cholecystectomy. The patients who come in with symptoms are often already past the stage where curative options apply, which is exactly why high-risk individuals need monitoring rather than waiting for a symptom to act on.” What Are the Early Signs of Gallbladder Cancer? The clinical picture in early gallbladder cancer is thin, which is what makes it hard to catch without active surveillance in patients who carry known risk factors. Pain in the upper right abdomen that comes and goes, particularly after fatty meals, tends to get managed as a gallstone symptom for months before imaging is ordered, and in patients who’ve had gallstones for years the new pattern often gets folded into the existing diagnosis rather than investigated as a change from it. Jaundice appearing without an obvious cause yellowing of the skin or whites of the eyes, sometimes with pale stools and dark urine points to biliary obstruction and in a patient over 50 with a gallstone history warrants urgent imaging rather than watchful waiting, because an obstructing gallbladder tumour can produce exactly this picture in its early spread to the bile ducts. Nausea and loss of appetite that hasn’t resolved over several weeks, particularly when accompanied by early satiety or a vague heaviness in the right upper quadrant, is a combination that’s easy to attribute to acidity or gastritis but that in practice shows up consistently in early gallbladder cancer patients before anything more specific develops. Unintended weight loss without a dietary explanation, running alongside any of the above, is the signal that turns a biliary complaint into an oncological workup, and the patients in whom it gets attributed to stress or busy schedules rather than investigated are the ones who tend to arrive late. These signs individually are nonspecific, but running together in a patient with gallstones or a prior polyp diagnosis, they warrant proper evaluation by a gallbladder cancer specialist rather than empirical management. Who Is at Risk and How Is It Detected? Risk in gallbladder cancer clusters around a well-defined set of factors, and knowing them is what determines who needs surveillance before symptoms appear. Gallstones, particularly large ones, carry the strongest association stones above 3 cm raise gallbladder cancer risk substantially compared to smaller stones, and patients who’ve had symptomatic gallstones for over a decade without cholecystectomy sit in a higher-risk category that warrants periodic imaging regardless of symptom status. Gallbladder polyps detected on ultrasound need size-based follow-up rather than a single normal report and discharge, because polyps above 1 cm carry meaningful malignant potential and those growing on serial imaging need histological assessment rather than continued surveillance. Porcelain gallbladder, a calcification of the gallbladder wall found incidentally on imaging, was historically considered a high cancer risk, and while the association is more nuanced than previously thought, patients with this finding need specialist review to determine whether the calcification pattern is one that warrants cholecystectomy. Women over 50 from northern India carry a particularly elevated baseline risk due to a combination of dietary, genetic, and environmental factors that epidemiological data has consistently identified, and this group benefits from lower investigation thresholds when biliary symptoms appear. Ultrasound is the starting point for detection, but EUS gives far more precise local staging information when a lesion is found. Read more on cancer warning signs to understand which clinical presentations across GI cancers need urgent imaging rather than a repeat clinic visit. Why Choose Dr. Vipulroy Rathod for Gallbladder Cancer? Dr. Vipulroy Rathod has been managing hepatobiliary and GI cancers at Fortis Hospital Mulund for over 30 years, and gallbladder cancer in particular has formed a significant part of his referred caseload given India’s elevated incidence rates, which means the clinical pattern recognition that separates an early finding from a late one is something his practice sees frequently enough to act on rather than reason through from first principles each time. Physicians from 35 countries have trained under his approach at Fortis, and that depth of experience shows most clearly in the complexity of the cases his team handles routinely. Book your consultation today with one of India’s most experienced specialists for gallbladder cancer risk assessment, early detection, and endoscopic staging. Book Appointment Call now Frequently Asked Questions What are the early signs of gallbladder cancer? Upper abdominal pain on the right side, nausea, unexplained weight loss, and jaundice are among the earliest signs, though many patients have no symptoms at all in the initial stages. Is gallbladder cancer related to gallstones? Yes. Long-standing gallstones, particularly large ones above 3 cm, are one of the most significant risk factors, though most people with gallstones do not develop cancer. How is gallbladder cancer diagnosed? Ultrasound is typically the first investigation, followed by CT or MRI for staging, and EUS for assessing local spread and lymph node involvement with greater accuracy than external imaging. Can gallbladder cancer be caught early? It can, but most cases are diagnosed incidentally during cholecystectomy or on imaging done for another reason, so high-risk patients with large gallstones or gallbladder polyps should be monitored regularly. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Colorectal cancer is consistently diagnosed at a later stage in India than necessary, not because the disease hides well but because its earliest symptoms are ones most people have a ready explanation for. Blood in the stool becomes a piles problem. Months of altered bowel habits become a diet conversation. The result is that patients arrive at a gastroenterologist with a disease that’s had time to grow while every individual symptom was being managed as something else entirely. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “The symptoms patients ignore most often are the ones I see most frequently in late-stage referrals. Rectal bleeding, unexplained weight loss, a change in stool frequency that’s been going on for weeks none of these should be dismissed without a proper workup, and yet most patients wait six months before mentioning them to a doctor.” Which Symptoms Do Patients Most Often Dismiss? These four presentations account for the majority of delayed diagnoses seen in referred colorectal cancer patients, and each one has a common benign explanation that absorbs the symptom before investigation happens. When blood appears in or on the stool, the assumption in most Indian households is haemorrhoids, and while piles are genuinely common, that assumption in practice functions as a reason not to investigate rather than a working diagnosis to confirm, and the colonoscopy that should have followed the very first episode gets deferred indefinitely. Altered bowel habits get absorbed into existing labels a patient with a prior IBS history who develops looser stools, increased urgency, or a shift to alternating constipation and diarrhoea will typically have the new pattern attributed to their existing condition rather than investigated as a change from it, which is exactly the clinical scenario where something early gets missed. Losing weight without trying is the symptom patients most frequently rationalise rather than investigate, particularly when they’re otherwise functional and not expecting a serious diagnosis, and in referred patients it’s routine to find that several kilograms disappeared over a three to four month period before anyone considered an oncological cause. In the lower abdomen, a heaviness or discomfort that antacids don’t resolve and that dietary adjustment hasn’t changed over several weeks is worth a scope rather than another empirical treatment trial, because a tumour causing early partial obstruction produces a picture that’s clinically indistinguishable from functional bloating without one. Any one of these lasting more than three weeks, or two of them appearing together, warrants investigation by a colorectal cancer specialist rather than further empirical management. Why Is Late Diagnosis So Consistent in the Indian Population? Several factors explain why this delay pattern repeats across patients from different backgrounds, ages, and cities, and understanding them is what makes earlier presentations possible. Throughout the months a colorectal cancer grows undiagnosed, the patient typically isn’t ignoring the symptom entirely but is instead managing it actively with a pharmacy product, a dietary change, or a home remedy, which produces enough functional relief to suppress the urgency to investigate further while the underlying disease continues. Talking about bowel function remains a genuine barrier in clinical interactions, and patients who wouldn’t hesitate to describe chest pain in detail will often omit rectal bleeding from a consultation, particularly when the appointment is nominally about something else and nobody asks directly. The absence of organised colorectal screening in India means that most people have never been told to consider a routine colonoscopy at age 45 regardless of symptoms, which is the single most effective structural intervention for catching this cancer early, and without that baseline expectation there’s no default prompt to investigate before something symptomatic develops. If a patient is under 50, the probability of colorectal cancer gets dismissed almost automatically, both by the patient and sometimes by the treating clinician, despite the fact that under-50 colorectal cancer rates are rising in India as they are globally and that younger patients who do present with it often do so at a more advanced stage precisely because of that age-based assumption. Understanding which of these presentations should trigger an urgent referral rather than another repeat consultation is where better outcomes start. Read more on cancer warning signs to know which clinical pictures need a scope without delay. Why Choose Dr. Vipulroy Rathod for Colorectal Cancer? Dr. Vipulroy Rathod has been treating colorectal cancer endoscopically at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 means the staging that decides between an endoscopic, laparoscopic, or open route happens accurately in the same workup. Patients referred for open surgery on lesions that were actually suitable for endoscopic removal frequently find a less invasive option available. Physicians from 35 countries have trained under his approach at Fortis.  Book your consultation today with one of India’s most experienced specialists for colorectal cancer screening, symptom evaluation, and endoscopic diagnosis. Book Appointment Call now Frequently Asked Questions What are the early symptoms of colorectal cancer? Blood in stool, unexplained change in bowel habits lasting more than three weeks, persistent bloating, and unintended weight loss are among the earliest signs that are most commonly dismissed. Why do Indians often ignore colorectal cancer symptoms? Most symptoms like bloating, irregular stools, and rectal bleeding are attributed to common conditions like piles or acidity, leading to delayed consultation and late-stage diagnosis. At what age should Indians get screened for colorectal cancer? Screening with colonoscopy is recommended from age 45 for average-risk individuals, and earlier for those with a family history of colorectal cancer or inflammatory bowel disease. Is blood in stool always a sign of colorectal cancer? Not always, but rectal bleeding should never be assumed to be piles without a proper examination, as colonoscopy is the only way to rule out colorectal cancer with certainty. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Endoscopic Mucosal Resection is a procedure that removes abnormal tissue or early-stage tumours from the lining of the digestive tract through an endoscope, without any cuts or open surgery. It’s used in the oesophagus, stomach, and colon, typically when a lesion is caught early enough that it hasn’t grown beyond the inner mucosal layer. The procedure combines diagnosis and treatment in a single sitting, which is what makes it clinically significant for patients where early-stage disease has been confirmed on prior imaging or endoscopy. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “EMR has changed what we can offer patients with early GI cancers. A lesion that would have meant major surgery ten years ago can now be removed endoscopically in under an hour, with the patient going home the same day and margins checked on histology within the week.” What Conditions Is EMR Used For? The procedure isn’t limited to one site or one diagnosis. Several GI conditions across different organs meet the criteria for EMR when the lesion is appropriately sized and confined to the mucosa. Barrett’s oesophagus with dysplasia: When Barrett’s progresses to high-grade dysplasia or early adenocarcinoma, EMR removes the affected segment before it invades deeper layers, effectively treating the cancer before it becomes a surgical problem. Early oesophageal and stomach cancers: Lesions confined to the mucosal layer, without lymph node involvement, are suitable candidates. Accurate pre-procedure staging with EUS is what determines whether EMR is appropriate or whether deeper invasion requires a different approach. Large colorectal polyps: Polyps too large or flat for standard snare polypectomy get removed via EMR, often in a piecemeal technique where the tissue is taken out in sections over the lesion’s surface. Submucosal lesions with surface involvement: Certain GI tumours that arise just beneath the mucosa but involve the surface layer can also be addressed endoscopically depending on their characteristics and location. Whether EMR is the right option depends entirely on lesion size, depth, and location factors assessed during workup rather than assumed at the time of the procedure. An endoscopic resection specialist can evaluate the findings and advise whether EMR, ESD, or surgery makes more clinical sense for a given case. How Is EMR Performed and What Should Patients Expect? Most patients arrive with a prior endoscopy report or biopsy result. The procedure itself builds on that workup. Submucosal injection: A fluid solution is injected beneath the lesion to lift it away from the deeper muscle layer. That separation is what makes safe resection possible without perforating the gut wall. Snare resection: A wire loop passed through the endoscope is placed around the lifted tissue and closed. A brief electrical current cuts through the base while sealing blood vessels at the same time, removing the lesion cleanly. Piecemeal removal for larger lesions: Lesions wider than 2 cm are often taken in multiple sections rather than a single pass. Each piece goes to histology separately, and the margins are assessed on the combined specimen. Recovery and follow-up: Patients are monitored for a few hours after the procedure and discharged the same day in most cases. A follow-up endoscopy at 3 to 6 months checks the resection site to confirm complete removal and look for any recurrence at the edges. Understanding which symptoms or findings should prompt investigation in the first place matters as much as knowing the procedure itself. Read more on cancer warning signs to know what presentations warrant urgent endoscopic evaluation. Why Choose Dr. Vipulroy Rathod for EMR? Dr. Vipulroy Rathod has been performing advanced therapeutic endoscopy at Fortis Hospital Mulund for over 30 years, with EMR forming a core part of his GI cancer practice since the technique became established in India. His EUS experience since 1998 means lesions are staged accurately before any resection decision is made, so patients aren’t taken to EMR when surgery is actually what’s needed, or pushed to surgery when EMR would suffice. Physicians from 35 countries have trained under his endoscopic approach, and referred patients regularly arrive having been told surgery was their only option. Book your consultation today with one of India’s most experienced specialists for early GI tumour assessment and endoscopic mucosal resection. Book Appointment Call now Frequently Asked Questions What is EMR in gastroenterology?  EMR stands for Endoscopic Mucosal Resection, a procedure that removes abnormal tissue or early-stage tumours from the GI tract lining through an endoscope without open surgery. Is EMR a major procedure?  No. EMR is a minimally invasive endoscopic procedure performed under sedation. Most patients are discharged the same day or within 24 hours. What conditions is EMR used to treat?  EMR is used to remove early-stage oesophageal, stomach, and colorectal cancers, large polyps, and precancerous lesions such as Barrett’s oesophagus with dysplasia. What is the difference between EMR and ESD?  EMR removes lesions in pieces using a snare, while ESD cuts beneath the lesion to remove it in one piece, allowing more accurate margin assessment for larger or complex lesions. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Oesophageal cancer grows in the lining of the food pipe and is most commonly linked to chronic acid reflux, tobacco use, and heavy alcohol intake. It presents in two forms: squamous cell carcinoma, which arises in the upper and middle oesophagus, and adenocarcinoma near the lower end, a type that’s become more prevalent as rates of long-term GERD rise. Late diagnosis is the rule rather than the exception here, because early-stage disease rarely causes symptoms distinct enough to trigger investigation. Risk assessment and timely endoscopic evaluation are what close that gap. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Most patients assume persistent swallowing difficulty is just acidity acting up. By the time they come in, the window for minimally invasive treatment has often passed. Anyone with chronic reflux or known risk factors should get scoped rather than just medicated.” What Are the Risk Factors for Oesophageal Cancer? This cancer builds over years, not weeks. Certain conditions and habits cause repeated mucosal injury, and it’s that accumulated damage over time that eventually tips into malignancy. Untreated acid reflux: Prolonged GERD causes the lower oesophageal lining to undergo a cellular change called Barrett’s oesophagus. It’s precancerous, and patients who’ve had reflux for years without adequate treatment carry a meaningfully higher adenocarcinoma risk than those whose reflux was managed properly. All forms of tobacco: Squamous cell carcinoma of the upper oesophagus is strongly tied to tobacco use in any form. Cigarettes cause consistent damage, but gutka and pan masala are particularly relevant in India, where chewing tobacco is widespread and often not discussed as a GI cancer risk by treating physicians. Heavy alcohol consumption: Regular heavy drinking erodes the oesophageal mucosa directly. When tobacco and alcohol coexist in the same patient, the combined risk is considerably greater than either factor produces on its own. Obesity: Excess abdominal weight increases intra-abdominal pressure, pushes gastric contents upward, and worsens reflux even in patients who don’t experience classic heartburn. That chronic low-grade acid exposure raises adenocarcinoma risk without the patient ever connecting the two. Patients carrying two or more of these factors shouldn’t wait for a swallowing problem before seeking evaluation. A referral to an oesophageal cancer specialist can clarify whether surveillance endoscopy makes clinical sense before anything turns symptomatic. How Is Oesophageal Cancer Detected? Stage at diagnosis is what determines whether a patient has treatment options or is managing a disease that’s already past the point of cure. These are the investigations that actually make that difference. Upper GI endoscopy: A flexible camera passed through the mouth gives a direct view of the oesophageal lining. Any area that looks abnormal gets biopsied on the spot, in the same sitting. It’s the starting point for any diagnostic workup where oesophageal pathology is suspected. Endoscopic ultrasound (EUS): Unlike external imaging, the EUS probe is placed inside the oesophagus itself, right against the wall being examined. That proximity allows it to assess tumour depth and regional lymph node involvement with a level of accuracy that CT simply can’t match for local staging. NBI endoscopy: Narrow band imaging works by filtering light to highlight the mucosal vessel architecture. Early flat lesions that look completely unremarkable under white-light endoscopy often show clearly abnormal vascular patterns under NBI, which is why high-risk patients shouldn’t be cleared on a standard scope alone. CT and PET-CT scanning: Once a cancer is confirmed endoscopically, cross-sectional imaging establishes whether it has spread beyond the oesophagus to regional nodes, liver, or lungs. That staging information is what determines whether the patient goes to endoscopic resection, surgery, or systemic treatment. Knowing which symptoms warrant urgent investigation matters as much as the investigations themselves. Read more on cancer warning signs to understand which clinical presentations need scoping without delay. Why Choose Dr. Vipulroy Rathod for Oesophageal Cancer? Dr. Vipulroy Rathod has been working in advanced GI endoscopy at Fortis Hospital Mulund for over 30 years. He started performing EUS in 1998, long before the technique became widely available in India, so oesophageal tumours get accurately staged in the same sitting rather than through a separate referral weeks down the line. NBI endoscopy in his practice has identified early oesophageal lesions in patients who’d previously been scoped elsewhere and cleared. Over 35 countries have sent physicians to train under his approach, which reflects the kind of clinical reputation that takes decades to build and doesn’t come from credentials alone. Book your consultation today with one of India’s most experienced specialists for oesophageal endoscopic diagnosis. Book Appointment Call now Frequently Asked Questions What are the main risk factors for oesophageal cancer? Chronic acid reflux, smoking, heavy alcohol use, obesity, and Barrett’s oesophagus are the leading risk factors for oesophageal cancer. How is oesophageal cancer detected early? Upper GI endoscopy with biopsy is the primary detection method. EUS and NBI endoscopy improve accuracy for staging and identifying early flat lesions. Can GERD lead to oesophageal cancer? Yes. Long-standing untreated GERD can cause Barrett’s oesophagus, a precancerous change that raises the risk of adenocarcinoma over time. Is oesophageal cancer treatable if caught early? Yes. Early-stage oesophageal cancer confined to the inner lining is highly treatable through endoscopic procedures such as EMR or ESD without open surgery. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Stomach cancer often produces vague early symptoms that mimic ordinary indigestion, which is why most cases are diagnosed at an advanced stage. Persistent dyspepsia, unexplained weight loss, early satiety, iron deficiency anaemia, and progressive difficulty swallowing are the features that should prompt endoscopy rather than another course of acid suppression. Diagnosis is by upper GI endoscopy with biopsy. Staging adds CT, EUS, and sometimes PET imaging.  According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Last month a patient came in with a year of indigestion. PPI for ten months. Eradication treatment for H. pylori twice. Nobody scoped him. By the time the diagnosis came, the cancer had grown through the wall. This is not an unusual case. It’s the typical case. In India, stomach cancer in the under-fifties is rising, and the threshold to scope persistent symptoms should be much lower than most doctors apply.” What are the early signs that should prompt evaluation? The early symptoms aren’t specific. Recognising when ordinary symptoms warrant investigation is what separates early-stage diagnosis from late presentation. Iron deficiency anaemia in adults: Men and post-menopausal women with low haemoglobin and low ferritin need both upper and lower endoscopy. Gastric cancer is a recognised cause of chronic occult bleeding in this group and the workup shouldn’t be delayed. Persistent dyspepsia that doesn’t settle on standard PPI treatment, particularly in patients over forty, with risk factors, or with family history of gastric cancer. Continuing empirical management beyond a few weeks delays diagnosis without changing outcomes. Unintentional weight loss: One of the strongest predictors on its own. Any patient losing weight without obvious cause, particularly with upper GI symptoms, needs imaging and endoscopy without delay. Early satiety and post-meal fullness can indicate a tumour reducing gastric capacity or causing obstruction at the antrum or pylorus. Often dismissed as functional dyspepsia in younger patients, which is part of why diagnosis gets delayed. The threshold to investigate should be low in higher-risk patients. Endoscopy services with NBI and chromoendoscopy capability detect early gastric cancers and precursor lesions that standard white-light examination can miss, particularly in patients with chronic atrophic gastritis or intestinal metaplasia. How is stomach cancer diagnosed and staged? Diagnosis is by endoscopy with biopsy. Staging adds imaging, EUS, and sometimes laparoscopy to decide whether the cancer is resectable. Endoscopy with biopsy: The definitive diagnostic test. Multiple biopsies from the lesion and the surrounding mucosa establish the histology, depth pattern, and the extent of mucosal involvement. EUS measures depth of invasion through the gastric wall and identifies regional lymph nodes. The information decides whether early lesions go to endoscopic resection or formal surgery. CT chest, abdomen, and pelvis: Standard staging investigation. Looks for liver metastases, peritoneal disease, and distant lymph nodes that change the treatment plan entirely. Staging laparoscopy in selected cases finds peritoneal metastases that CT missed. Particularly useful in linitis plastica and advanced presentations where occult peritoneal disease is common. Accurate staging changes the treatment plan completely. Read more on Role of endoscopy  for how stomach cancer detection fits into the broader screening strategy for high-risk patients. Why choose Dr. Vipulroy Rathod for stomach cancer assessment? Dr. Vipulroy Rathod has been performing upper GI endoscopy and EUS at Fortis Hospital Mulund since the late 1990s, with the volume of cases that builds pattern recognition for early gastric disease. Most patients arrive after months or years of PPI treatment for symptoms that should have triggered a scope earlier. Recognising the patterns that warrant endoscopy, and then identifying the subtle changes once the scope is in, separates early-stage diagnosis from advanced disease. The harder problem isn’t the diagnosis. It’s that no one suspected cancer in the first place. Indian patients with chronic dyspepsia get treated for years before anyone scopes them. Lowering the threshold to investigate in patients over forty with persistent symptoms, family history, or alarm features is what changes outcomes at scale. Book your consultation today with one of India’s most experienced specialists for stomach cancer assessment and endoscopic diagnosis. Book Appointment Call now Frequently Asked Questions At what age should I be concerned about stomach cancer? Over forty with persistent symptoms or family history. The threshold drops further with H. pylori infection or known chronic gastritis. Can stomach cancer be detected on blood tests? Not reliably enough to base a diagnosis on. Tumour markers like CEA and CA 19-9 lack the sensitivity, and endoscopy with biopsy remains the standard for confirmation. Does H. pylori cause stomach cancer? Yes, chronic H. pylori infection is a major risk factor for gastric adenocarcinoma, particularly the distal type. Eradication reduces but doesn’t eliminate the long-term risk in patients with established mucosal changes. Is stomach cancer curable if found early? Yes,stage one survival exceeds ninety percent with surgery or endoscopic resection, falling sharply with delayed diagnosis. Early endoscopy in symptomatic patients is what makes the difference. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.